Skip to Main Content

Paper Details

Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies.
Blood Adv
3
2023
AML, AML and CLL stromal coculture, B, B-cell receptor, CLL, CLL cells, JAK, STAT, STAT3, Stromal coculture, acute myeloid leukemia, bone marrow stromal cells, cancer, chronic lymphocytic leukemia, coculture, hematological malignancies, mono, monoculture, primary, primary blood cancer, ruxolitinib, stromal cells, tofacitinib, tumor, tumor cells

Datasets

Release 1.2